valiant semaglutide Semaglutide Weight Loss New 7.2mg Wegovy Pens Now

The only FDA-approved GLP-1 class medications for obesity are semaglutide (Wegovy) and tirzepatide (Zepbound)

GLP-1 medications offer the unusual combination of potent glucose lowering with weight loss and low hypoglycemia risk, explaining their rising prominence

Following 30 minutes of low intensity exercise, muscle glycogen content was 35% greater, indicating increased fatty acid utilization

For patients seeking more aggressive metabolic intervention, PlexusDx provides Compounded Tirzepatide Injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) or GLP-Squared Injectiona dual-compound formula combining semaglutide and tirzepatide at $289/month